IDH1 and glioblastoma: In one case (Fig. 2a: GS-15), a patient diagnosed with an IDH wildtype, MGMT promoter methylated, right frontal GBM, underwent a gross total resection, treatment with concurrent temozolomide/radiation, and 12 months of adjuvant temozolomide.